Encorafenib plus binimetinib and encorafenib monotherapy showed favourable efficacy compared with vemurafenib in patients with BRAF-mutant melanoma. https://t.co/nOziVH7Lan #umkcrct
5 followers
2,358 followers
Phase 3 trials of BRAF-MEK inhibition: Dabrafenib + Trametinib: COMBI-V (vs vem); BREAK-3 (vs dab mono) https://t.co/o6awrf5USa https://t.co/FeC2jTRdkR Vemurafenib + Cobimetinib (coBRIM) https://t.co/pAQpCIxoYb Encorafenib + Binimetinib: https://t.co/uS
910 followers
@SBRInvestor Seems that encorafenib+ binimetinib is better tolerated- COLUMBUS trial https://t.co/Hr1neqyUuY
1,686 followers
RT @TheLancetOncol: In our Oct issue: #phase3 #trial of encorafenib + binimetinib vs vemurafenib or encorafenib alone in patients with BRAF…